UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 343

Sortiert nach

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

CNS drugs, 2014-05, Vol.28 (5), p.421-453

2014

Link zum Volltext

Verfügbarkeit prüfen

C.02.01 Efficacy and tolerability of antipsychotic treatment

European neuropsychopharmacology, 2014-10, Vol.24, p.S752-S753

Peuskens, J

2014

Link zum Volltext

Verfügbarkeit prüfen

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Acta psychiatrica Scandinavica, 2016-01, Vol.133 (1), p.5-22

2016

Link zum Volltext

Verfügbarkeit prüfen

Validité des psychoses fonctionnelles non affectives du DSM IV dans une population congolaise. Une étude clinique transversale

Encéphale, 2011-04, Vol.37 (2), p.101-109

2011

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

British journal of psychiatry, 2011-08, Vol.199 (2), p.99-105

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects

Journal of affective disorders, 2010-04, Vol.122 (1), p.60-67

2010

Link zum Volltext

Verfügbarkeit prüfen

Second-generation antipsychotics and constipation: A review of the literature

European psychiatry, 2011-01, Vol.26 (1), p.34-44

2011

Link zum Volltext

Verfügbarkeit prüfen

How are we assessing functioning in schizophrenia? A need for a consensus approach

European psychiatry, 2012-08, Vol.27 (6), p.391-395

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy

Journal of affective disorders, 2009-07, Vol.116 (1), p.106-112

2009

Link zum Volltext

Verfügbarkeit prüfen

Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study

Schizophrenia research, 2013-06, Vol.147 (1), p.132-139

2013

Link zum Volltext

Verfügbarkeit prüfen

No gender differences in social outcome in patients suffering from schizophrenia

European psychiatry, 2012-08, Vol.27 (6), p.406-408

2012

Link zum Volltext

Verfügbarkeit prüfen

O26 Incidence différente des anomalies glycémiques et métaboliques en fonction du diagnostic psychiatrique de troubles bipolaires, schizophrénie et désordres schizoaffectifs

Diabetes & metabolism, 2008, Vol.34, p.H17-H17

2008

Link zum Volltext

Verfügbarkeit prüfen

Standardized remission criteria in schizophrenia

Acta psychiatrica Scandinavica, 2006-02, Vol.113 (2), p.91-95

2006

Link zum Volltext

Verfügbarkeit prüfen

Tentative de diagnostic différentiel des psychoses fonctionnelles non affectives au moyen des tests neuropsychologiques dans une population congolaise

Annales médico psychologiques, 2009-12, Vol.167 (10), p.767-773

2009

Link zum Volltext

Verfügbarkeit prüfen

Setting new standards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria

European psychiatry, 2012-04, Vol.27 (3), p.170-175

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Clinical practice and epidemiology in mental health, 2006-06, Vol.2 (1), p.14-14

2006

Link zum Volltext

Verfügbarkeit prüfen

Troubles métaboliques associés aux antipsychotiques atypiques : consensus belge sur la conduite à tenir

Encéphale, 2007-04, Vol.33 (2), p.197-202

2007

Link zum Volltext

Verfügbarkeit prüfen

P.3.c.001 Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortality

European neuropsychopharmacology, 2008, Vol.18, p.S404-S405

Peuskens, J

2008

Link zum Volltext

Verfügbarkeit prüfen

C.10.02 Can switching to depots improve antipsychotic maintenance treatment?

European neuropsychopharmacology, 2008, Vol.18, p.S598-S598

Peuskens, J

2008

Link zum Volltext

Verfügbarkeit prüfen

Physical health management in psychiatric settings

European psychiatry, 2010-06, Vol.25 (S2), p.S22-S28

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

Current medical research and opinion, 2009-09, Vol.25 (9), p.2197-2206

2009

Link zum Volltext

Verfügbarkeit prüfen

A study of the family burden of 150 family members of schizophrenic patients

European psychiatry, 2004-11, Vol.19 (7), p.395-401

2004

Link zum Volltext

Verfügbarkeit prüfen

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Acta psychiatrica Scandinavica, 1997-10, Vol.96 (4), p.265-273

1997

Link zum Volltext

Verfügbarkeit prüfen

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial

Schizophrenia bulletin, 2011-03, Vol.37 (2), p.352-361

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

Current medical research and opinion, 2010-03, Vol.26 (3), p.501-509

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 343

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Psychiatry
(151)
Humans
(136)
Science & Technology
(132)
Life Sciences & Biomedicine
(130)
Schizophrenia
(94)
Female
(93)
Adult
(85)
Male
(85)
Biological And Medical Sciences
(84)
Medical Sciences
(80)
Psychology. Psychoanalysis. Psychiatry
(78)
Psychopathology. Psychiatry
(61)
Schizophrenia - Drug Therapy
(57)
Antipsychotic Agents - Therapeutic Use
(50)
Adult And Adolescent Clinical Studies
(45)
Internal Medicine
(45)
Middle Aged
(42)
Pharmacology. Drug Treatments
(40)
Psychoses
(40)
Neuropharmacology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

C.02.01 Efficacy and tolerability of antipsychotic treatment

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Validité des psychoses fonctionnelles non affectives du DSM IV dans une population congolaise. Une étude clinique transversale

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects

Second-generation antipsychotics and constipation: A review of the literature

How are we assessing functioning in schizophrenia? A need for a consensus approach

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy

Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study

No gender differences in social outcome in patients suffering from schizophrenia

O26 Incidence différente des anomalies glycémiques et métaboliques en fonction du diagnostic psychiatrique de troubles bipolaires, schizophrénie et désordres schizoaffectifs

Standardized remission criteria in schizophrenia

Tentative de diagnostic différentiel des psychoses fonctionnelles non affectives au moyen des tests neuropsychologiques dans une population congolaise

Setting new standards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Troubles métaboliques associés aux antipsychotiques atypiques : consensus belge sur la conduite à tenir

P.3.c.001 Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortality

C.10.02 Can switching to depots improve antipsychotic maintenance treatment?

Physical health management in psychiatric settings

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

A study of the family burden of 150 family members of schizophrenic patients

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

Suchergebnisse filtern